首页> 美国卫生研究院文献>other >Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation
【2h】

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

机译:非许可的HLA-DPB1 T细胞表位组错配的方向性不能改善8/8相匹配的无关供体造血细胞移植的临床风险分层

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In 8/8 HLA-matched unrelated donor (UD) hematopoietic cell transplantation (HCT), HLA-DPB1 mismatches between alleles from different T-cell epitope (TCE) groups (non-permissive mismatches) are associated with significantly higher risks of mortality compared to those between alleles from the same TCE group (permissive mismatches); however, the relevance of mismatch directionality (host vs graft [uni-directional HvG], graft vs host [uni-directional GvH] or both [bi-directional]) in the non-permissive setting is unknown. We show here significantly higher in vitro relative responses (RR) to bi-directional mismatches compared to uni-directional HvG or GvH mismatches in a total of 420 one-way mixed lymphocyte reactions between 10/10 matched pairs (RR 27.5 vs 7.5 vs 15.5, respectively, p<0.001). However, in 3281 8/8 matched UD HCT for leukemia or myelodysplastic syndrome, the hazards of transplant-related mortality (TRM) were similar for uni-directional HvG or GvH mismatches and bi-directional mismatches (HR 1.32, p=0.001 vs HR 1.28, p=0.005 and HR 1.34, p=0.046), compared to permissive mismatches. Similar results were observed for overall survival. No statistical differences between the uni- and the bi-directional non-permissive groups were detected in pairwise comparisons for any of the outcomes tested. We conclude that consideration of directionality does not improve risk stratification by non-permissive HLA-DPB1 TCE mismatches in UD searches.
机译:在8/8 HLA匹配的无关供体(UD)造血细胞移植(HCT)中,来自不同T细胞表位(TCE)组的等位基因之间的HLA-DPB1错配(非允许错配)与死亡率相比明显更高同一TCE组等位基因之间的那些(允许错配);但是,在非许可设置中,不匹配方向性(宿主与移植物[单向HvG],移植物与宿主[单向GvH]或两者[双向])的相关性未知。我们在此处显示了在10/10对配对之间总共420次单向混合淋巴细胞反应中,与单向HvG或GvH错配相比,对双向错配的体外相对响应(RR)明显更高(RR 27.5 vs 7.5 vs 15.5分别为p <0.001)。然而,在3281 8/8匹配的UD HCT用于白血病或骨髓增生异常综合征中,单向HvG或GvH错配和双向错配的移植相关死亡率(TRM)的危险相似(HR 1.32,p = 0.001 vs HR与允许的不匹配相比,p = 1.28,p = 0.005,HR = 1.34,p = 0.046)。总体存活率观察到相似的结果。在成对比较中,对于任何测试结果,未发现单向和双向非许可组之间的统计差异。我们得出结论,在UD搜索中,对方向性的考虑不会因非许可的HLA-DPB1 TCE不匹配而改善风险分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号